| 1 |
34269222 | Pramipexole, a dopamine D3/D2 receptor-preferring agonist, attenuates reserpine-induced fibromyalgia-like model in mice. | 2022 Feb |
2 |
| 2 |
34699917 | Pramipexole regulates depression-like behavior via dopamine D3 receptor in a mouse model of Parkinson's disease. | 2021 Dec |
1 |
| 3 |
31538542 | DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis. | 2020 Jul |
3 |
| 4 |
30423289 | GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells. | 2019 Jul 1 |
1 |
| 5 |
26801190 | Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice. | 2017 Mar |
3 |
| 6 |
27261607 | Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway. | 2016 Jul |
2 |
| 7 |
23311775 | Age-dependent dystonia in striatal Gγ7 deficient mice is reversed by the dopamine D2 receptor agonist pramipexole. | 2013 Mar |
1 |
| 8 |
23643745 | Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands. | 2013 Sep |
1 |
| 9 |
20122926 | Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade. | 2010 Jun |
1 |
| 10 |
14985923 | The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. | 2004 Sep |
1 |